You Searched For "biontech stock price" and got 20 results
Sort By:
2 mins read
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
The companies aim to apply for emergency-use authorization within days. If approved, the vaccine co…
Ben Winck
1 min read
Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status
The candidates that received fast track status are the most advanced of four potential vaccines bei…
Carmen Reinicke
2 mins read
Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine
The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…
Matthew Fox
1 min read
Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill
The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…
Matthew Fox
1 min read
BioNTech soars 7% after its vaccine appears to work against new variants of COVID-19
"So we've now tested 16 different mutations, and none of them have really had any significant impac…
Matthew Fox
1 min read
Nearly 36,000 Robinhood users added Pfizer shares Wednesday after the US government ordered 100 million doses of its coronavirus vaccine
Pfizer is the most-added stock on Robinhood in the last 24 hours, according to data from Robintrack…
Carmen Reinicke
1 min read
Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine
Adding the vaccine "increases the odds that we will have a safe, effective vaccine as soon as the e…
Carmen Reinicke
1 min read
BioNTech soars after COVID-19 vaccine drives monster earnings beat and stronger guidance
BioNTech saw a more than 7,000% jump in revenue year-over-year from €27 million to €2 billion, driv…
Matthew Fox
2 mins read
Moderna was the most-bought stock for retail traders in the week leading up to its 16% single-day plunge
Wall Street analysts appear less keen than retail traders on vaccine makers such as Moderna, after …
Harry Robertson
2 mins read
Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world
"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…
Matthew Fox
1 min read
Meet the married billionaire couple who helped create the Pfizer vaccine
BioNTech's CEO, Dr. Ugur Sahin, cofounded the firm with his wife, Dr. Özlem Türeci, who is the chie…
Juliana Kaplan
2 mins read
The billionaire scientist who developed Pfizer's breakthrough vaccine has not sold any shares in partner BioNTech's surging stock
Sahin and his wife, Ozlem Tureci, are the "dream team" couple whose company partnered with Pfizer t…
Shalini Nagarajan
1 min read
A billionaire couple is behind the historic coronavirus vaccine
Dr. Ugur Sahin and Dr. Özlem Türeci cofounded BioNTEch, which teamed with Pfizer on the coronavirus…
Juliana Kaplan
1 min read
Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns
The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …
Isabelle Lee
2 mins read
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial
The 52-week high for Pfizer stock is $41.99, which means CEO Albert Bourla sold his shares at close…
Shalini Nagarajan
1 min read
Pfizer extends 5-day gain to record territory as US recommends COVID-19 booster shot
Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …
Matthew Fox
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
1 min read
Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval
The companies "believe in their capability to distribute the vaccine globally upon approval or auth…
Matthew Fox
2 mins read
The S&P 500 just blasted through a key technical level, suggesting further stock-market upside to come
Monday's breakout in stocks generated a measured move price target of 3,825, representing upside po…
Matthew Fox
1 min read
BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead
Vaccine demand is likely to persist well into next year, the company said, with more than a billion…